A novel FFA1 agonist, CPU025, improves glucose-lipid metabolism and alleviates fatty liver in obese-diabetic (ob/ob) mice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel FFA1 agonist, CPU025, improves glucose-lipid metabolism and alleviates fatty liver in obese-diabetic (ob/ob) mice

Published:2020-03 Issue: Volume:153 Page:104679
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Li Zheng,Liu Chunxia,Zhou Zongtao,Hu Lijun,Deng Liming,Ren Qiang,Qian Hai

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Guangdong Basic and Applied Basic Research Foundation

Guangdong Pharmaceutical University

Innovative strong school project of Guangdong Pharmaceutical University

Publisher

Elsevier BV

Subject

Pharmacology

Reference58 articles.

1. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus;DeFronzo;Diabetes,2009

2. Burden Metab Risk Factors. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants;Danaei;Lancet,2011

3. Microvascular and macrovascular complications of diabetes;Fowler;Clin. Diabetes,2011

4. The importance of synthetic drugs for type 2 diabetes drug discovery;Safavi;Expert Opin Drug Dis,2013

5. A review of the efficacy and safety of oral antidiabetic drugs;Stein;Expert Opin. Drug Saf.,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Nutritional Veil of Sulforaphane: With a Major Focus on Glucose Homeostasis Modulation;Nutrients;2024-06-14

2. Metabolite profiles of diabetes mellitus and response to intervention in anti-hyperglycemic drugs;Frontiers in Endocrinology;2023-10-31

3. Free Fatty Acid Receptors (FFARs): Emerging Therapeutic Targets for the Management of Diabetes Mellitus;Current Medicinal Chemistry;2023-09

4. Predicting GPR40 Agonists with A Deep Learning‐Based Ensemble Model;ChemistryOpen;2023-07-05

5. Anti-inflammatory effects and improved metabolic derangements in ob/ob mice by a newly synthesized prenylated benzopyran with pan-PPAR activity;Pharmacological Research;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3